The clearance gives physicians greater flexibility in treating chronic pain, minimizing MRI-related limitations with whole-body MRI-conditional use. Nalu’s system now enables personalized care without compromising future diagnostic imaging needs.

Carlsbad, California–based Nalu offers FDA-cleared spinal cord stimulation and peripheral nerve stimulation technology. It designed its offerings to treat patients with chronic neuropathic pain. It delivers gentle electrical pulses to the nervous system to modulate pain signals before they reach the brain.

Nalu’s system includes a fully featured, battery-free, miniaturized implantable pulse generator (IPG). An externally worn therapy disc wirelessly powers the IPG and the user can control it through a smartphone-based app. The company says its IPG, despite its smaller size, delivers treatment capabilities similar to larger IPGs. Nalu’s system also has an expected service life of 18 years.